Price T Rowe Associates Inc Celldex Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,880,365 shares of CLDX stock, worth $75.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,880,365
Previous 3,172,399 9.21%
Holding current value
$75.5 Million
Previous $117 Million 16.61%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$32.06 - $44.56 $9.36 Million - $13 Million
-292,034 Reduced 9.21%
2,880,365 $97.9 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $2.79 Million - $3.63 Million
85,191 Added 2.76%
3,172,399 $117 Million
Q1 2024

May 15, 2024
BUY
$35.22 - $51.88 $93.9 Million - $138 Million
2,664,915 Added 631.06%
3,087,208 $130 Million
Q4 2023

Feb 14, 2024
SELL
$22.61 - $40.65 $1.03 Million - $1.86 Million
-45,762 Reduced 9.78%
422,293 $16.7 Million
Q3 2023

Nov 14, 2023
SELL
$25.45 - $37.46 $267,708 - $394,041
-10,519 Reduced 2.2%
468,055 $12.9 Million
Q2 2023

Aug 14, 2023
SELL
$30.29 - $38.28 $7.12 Million - $9 Million
-234,988 Reduced 32.93%
478,574 $16.2 Million
Q1 2023

May 15, 2023
SELL
$34.78 - $47.43 $4.15 Million - $5.67 Million
-119,447 Reduced 14.34%
713,562 $25.7 Million
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $2.42 Million - $3.95 Million
87,001 Added 11.66%
833,009 $37.1 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $4.83 Million - $7.99 Million
212,606 Added 39.86%
746,008 $21 Million
Q2 2022

Aug 15, 2022
SELL
$20.5 - $37.33 $10.7 Million - $19.4 Million
-520,923 Reduced 49.41%
533,402 $14.4 Million
Q1 2022

May 16, 2022
BUY
$27.64 - $39.32 $3.83 Million - $5.45 Million
138,717 Added 15.15%
1,054,325 $35.9 Million
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $1.33 Million - $2.09 Million
37,199 Added 4.23%
915,608 $35.4 Million
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $14.2 Million - $27.4 Million
489,361 Added 125.78%
878,409 $47.4 Million
Q2 2021

Aug 16, 2021
BUY
$20.71 - $35.37 $1.18 Million - $2.01 Million
56,818 Added 17.1%
389,048 $13 Million
Q1 2021

May 17, 2021
BUY
$16.19 - $29.91 $634,032 - $1.17 Million
39,162 Added 13.36%
332,230 $6.84 Million
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $4.39 Million - $6.67 Million
293,068 New
293,068 $5.14 Million

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.23B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email